These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

88 related items for PubMed ID: 7493339

  • 1. Initial studies of monoclonal antibody PAM4 targeting to xenografted orthotopic pancreatic cancer.
    Alisauskus R, Wong GY, Gold DV.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5743s-5748s. PubMed ID: 7493339
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Radioimmunotherapy of experimental pancreatic cancer with 131I-labeled monoclonal antibody PAM4.
    Gold DV, Cardillo T, Vardi Y, Blumenthal R.
    Int J Cancer; 1997 May 16; 71(4):660-7. PubMed ID: 9178823
    [Abstract] [Full Text] [Related]

  • 7. Fractionated radioimmunotherapy of human colon carcinoma xenografts with 131I-labeled monoclonal antibody CC49.
    Buchsbaum D, Khazaeli MB, Liu T, Bright S, Richardson K, Jones M, Meredith R.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5881s-5887s. PubMed ID: 7493364
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo reactivity of an internalizing antibody, RS7, with human breast cancer.
    Shih LB, Xuan H, Aninipot R, Stein R, Goldenberg DM.
    Cancer Res; 1995 Dec 01; 55(23 Suppl):5857s-5863s. PubMed ID: 7493360
    [Abstract] [Full Text] [Related]

  • 10. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N, Saga T, Sakahara H, Yao Z, Nakamoto Y, Zhang M, Kuroki M, Matsuoka Y, Iida Y, Konishi J.
    J Nucl Med; 1999 Apr 01; 40(4):685-92. PubMed ID: 10210230
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
    Clarke K, Lee FT, Brechbiel MW, Smyth FE, Old LJ, Scott AM.
    Clin Cancer Res; 2000 Sep 01; 6(9):3621-8. PubMed ID: 10999754
    [Abstract] [Full Text] [Related]

  • 12. Radioimmunotherapy of colorectal cancer in small volume disease and in an adjuvant setting: preclinical evaluation in comparison to equitoxic chemotherapy and initial results of an ongoing phase-I/II clinical trial.
    Behr TM, Memtsoudis S, Vougioukas V, Liersch T, Gratz S, Schmidt F, Lorf T, Post S, Wörmann B, Hiddemann W, Ringe B, Becker W.
    Anticancer Res; 1999 Sep 01; 19(4A):2427-32. PubMed ID: 10470170
    [Abstract] [Full Text] [Related]

  • 13. Improved targeting of pancreatic cancer: experimental studies of a new bispecific antibody, pretargeting enhancement system for immunoscintigraphy.
    Cardillo TM, Karacay H, Goldenberg DM, Yeldell D, Chang CH, Modrak DE, Sharkey RM, Gold DV.
    Clin Cancer Res; 2004 May 15; 10(10):3552-61. PubMed ID: 15161715
    [Abstract] [Full Text] [Related]

  • 14. Targeting strategies for cancer radiotherapy.
    Buchsbaum DJ, Rogers BE, Khazaeli MB, Mayo MS, Milenic DE, Kashmiri SV, Anderson CJ, Chappell LL, Brechbiel MW, Curiel DT.
    Clin Cancer Res; 1999 Oct 15; 5(10 Suppl):3048s-3055s. PubMed ID: 10541342
    [Abstract] [Full Text] [Related]

  • 15. Single-Dose versus fractionated radioimmunotherapy of human colon carcinoma xenografts using 131I-labeled multivalent CC49 single-chain fvs.
    Goel A, Augustine S, Baranowska-Kortylewicz J, Colcher D, Booth BJ, Pavlinkova G, Tempero M, Batra SK.
    Clin Cancer Res; 2001 Jan 15; 7(1):175-84. PubMed ID: 11205906
    [Abstract] [Full Text] [Related]

  • 16. 186Re-labeled monoclonal antibody E48 immunoglobulin G-mediated therapy of human head and neck squamous cell carcinoma xenografts.
    Gerretsen M, Visser GW, van Walsum M, Meijer CJ, Snow GB, van Dongen GA.
    Cancer Res; 1993 Aug 01; 53(15):3524-9. PubMed ID: 8339258
    [Abstract] [Full Text] [Related]

  • 17. Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
    Horak E, Hartmann F, Garmestani K, Wu C, Brechbiel M, Gansow OA, Landolfi NF, Waldmann TA.
    J Nucl Med; 1997 Dec 01; 38(12):1944-50. PubMed ID: 9430475
    [Abstract] [Full Text] [Related]

  • 18. Radioimmunotherapy of head and neck cancer xenografts using 131I-labeled antibody L19-SIP for selective targeting of tumor vasculature.
    Tijink BM, Neri D, Leemans CR, Budde M, Dinkelborg LM, Stigter-van Walsum M, Zardi L, van Dongen GA.
    J Nucl Med; 2006 Jul 01; 47(7):1127-35. PubMed ID: 16818947
    [Abstract] [Full Text] [Related]

  • 19. Radioimmunotherapy of human colon cancer xenografts using a dimeric single-chain Fv antibody construct.
    Pavlinkova G, Booth BJ, Batra SK, Colcher D.
    Clin Cancer Res; 1999 Sep 01; 5(9):2613-9. PubMed ID: 10499640
    [Abstract] [Full Text] [Related]

  • 20. Radioimmunotherapy of nude mice bearing a human interleukin 2 receptor alpha-expressing lymphoma utilizing the alpha-emitting radionuclide-conjugated monoclonal antibody 212Bi-anti-Tac.
    Hartmann F, Horak EM, Garmestani K, Wu C, Brechbiel MW, Kozak RW, Tso J, Kosteiny SA, Gansow OA, Nelson DL.
    Cancer Res; 1994 Aug 15; 54(16):4362-70. PubMed ID: 8044783
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.